John Ramunas and Glenn Markov lead Rejuvenation Technologies in its pursuit to treat age-related conditions. Their product, RTI-LIV, targets Compensated Cirrhosis, aiming to utilize telomere extension as a therapeutic approach against aging.
×
Rejuvenation Technologies � RTI-LIV(Compensated Cirrhosis)
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD